Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,921 | 879 | 99.9% |
| Education | $9.75 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,144 | 111 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,076 | 101 | $0 (2024) |
| ABBVIE INC. | $1,998 | 116 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $980.03 | 50 | $0 (2024) |
| Amgen Inc. | $801.80 | 40 | $0 (2024) |
| Novo Nordisk Inc | $676.28 | 37 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $660.43 | 26 | $0 (2024) |
| PFIZER INC. | $644.46 | 38 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $563.66 | 35 | $0 (2022) |
| Esperion Therapeutics, Inc. | $526.04 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,909 | 123 | ABBVIE INC. ($724.58) |
| 2023 | $2,311 | 112 | ABBVIE INC. ($378.99) |
| 2022 | $2,268 | 116 | ABBVIE INC. ($346.78) |
| 2021 | $2,461 | 128 | AbbVie Inc. ($409.74) |
| 2020 | $2,078 | 101 | GlaxoSmithKline, LLC. ($251.23) |
| 2019 | $1,639 | 94 | AstraZeneca Pharmaceuticals LP ($307.56) |
| 2018 | $1,504 | 98 | AstraZeneca Pharmaceuticals LP ($209.18) |
| 2017 | $1,760 | 109 | GlaxoSmithKline, LLC. ($367.61) |
All Payment Transactions
881 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $124.04 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Endocrinology | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $32.26 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.66 | General |
| Category: Cardiovascular | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,444 | 1,890 | $174,776 | $91,050 |
| 2022 | 18 | 2,039 | 2,691 | $212,039 | $117,266 |
| 2021 | 17 | 2,395 | 3,183 | $251,131 | $141,134 |
| 2020 | 22 | 2,471 | 3,258 | $271,244 | $131,924 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 260 | 460 | $66,700 | $28,500 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 151 | 151 | $22,650 | $20,987 | 92.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 150 | $29,250 | $13,839 | 47.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 93 | 94 | $9,400 | $7,834 | 83.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 36 | $9,720 | $4,870 | 50.1% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 168 | 168 | $8,400 | $4,652 | 55.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $2,800 | $2,488 | 88.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 163 | 196 | $11,760 | $2,088 | 17.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 140 | 248 | $3,720 | $2,075 | 55.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 40 | $3,600 | $1,531 | 42.5% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 166 | 166 | $1,992 | $712.14 | 35.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 25 | 25 | $1,250 | $503.75 | 40.3% |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Office | 2023 | 11 | 19 | $950.00 | $440.26 | 46.3% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 98 | 109 | $1,744 | $429.46 | 24.6% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 14 | 14 | $840.00 | $100.24 | 11.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 286 | 581 | $79,635 | $35,437 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 158 | 158 | $23,700 | $22,549 | 95.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 125 | $23,425 | $11,791 | 50.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 136 | 136 | $10,670 | $9,184 | 86.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 96 | 96 | $9,600 | $8,305 | 86.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 169 | 170 | $6,800 | $5,440 | 80.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 34 | $8,870 | $5,035 | 56.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 52 | 111 | $9,040 | $4,346 | 48.1% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 130 | 130 | $6,500 | $3,693 | 56.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 18 | 18 | $2,480 | $2,348 | 94.7% |
About Dr. Peter Licht, M.D
Dr. Peter Licht, M.D is a Internal Medicine healthcare provider based in Newtown, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841267457.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Licht, M.D has received a total of $16,931 in payments from pharmaceutical and medical device companies, with $2,909 received in 2024. These payments were reported across 881 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($16,921).
As a Medicare-enrolled provider, Licht has provided services to 8,349 Medicare beneficiaries, totaling 11,022 services with total Medicare billing of $481,374. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Newtown, CT
- Active Since 03/02/2006
- Last Updated 09/11/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1841267457
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,088
- JARDIANCE (Drug) $780.71
- VRAYLAR (Drug) $767.36
- FARXIGA (Drug) $764.26
- Kerendia (Drug) $660.43
- UBRELVY (Drug) $633.54
- SYMBICORT (Drug) $630.12
- QULIPTA (Drug) $547.54
- XARELTO (Drug) $490.35
- REXULTI (Drug) $465.74
- BREZTRI (Drug) $459.96
- Vascepa (Drug) $395.06
- Ozempic (Drug) $383.82
- AREXVY (Drug) $344.03
- BREO (Drug) $318.80
- NEXLETOL (Drug) $276.04
- ENTRESTO (Drug) $271.13
- ELIQUIS (Drug) $265.37
- Otezla (Drug) $257.50
- NEXLIZET (Drug) $250.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newtown
Jennifer Holloway, M.d, M.D
Internal Medicine — Payments: $23,629
Anil Patel, M.d, M.D
Internal Medicine — Payments: $12,019
Jeffrey Friedman, Md, MD
Internal Medicine — Payments: $4,912
Giacomo Mangiaracina, Md, MD
Internal Medicine — Payments: $3,284
Dr. Waseem Butt, Md, MD
Internal Medicine — Payments: $726.09
Dr. Flora Parvin, Md, MD
Internal Medicine — Payments: $414.22